Accelerating the commercialisation of a disruptive analytical technology which enables the biopharmaceutical industry to manufacture drugs faster, cheaper and with greater regulatory confidence

Project Information

BIOSIM

Grant agreement ID: 778586

DOI

10.3030/778586

Project closed

EC signature date 19 September 2017

Start date 1 October 2017

End date 31 May 2019

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost

€ 2 029 325,00

EU contribution

€ 2 029 325,00

Coordinated by

VALITACELL LTD
Ireland

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Demonstrators, pilots, prototypes (3)

CE marked product

Ensuring that Valitacell product and associated has the required CE registration

Peer reviewed publication submitted

Submission of results and outline of applicability and benefits of technology in a report to be published in a peer reviewed journal or online publication

Results exchanged

Review of the results from the four sites and analysis of same in order to determine the final model to be adopted in the product

Publications

Peer reviewed articles (1)

High-throughput quantitation of Fc-containing recombinant proteins in cell culture supernatant by fluorescence polarization spectroscopy

Author(s): Ben Thompson, Jerry Clifford, Mike Jenns, Andrew Smith, Ray Field, Kalpana Nayyar, David C. James
Published in: Analytical Biochemistry, Issue 534, 2017, Page(s) 49-55, ISSN 0003-2697
Publisher: Academic Press
DOI: 10.1016/j.ab.2017.07.013

Intellectual Property Rights

Patent (9)

A METHOD OF PREDICTING PHENOTYPIC INSTABILITY IN A CELL

Application/Publication number: EP 15718799
Date: 2015-04-02
Applicant(s): VALITACELL LTD

A METHOD OF MEASURING ANTIBODY CONCENTRATION IN A SAMPLE

Application/Publication number: EP 15736411
Date: 2015-06-18
Applicant(s): VALITACELL LTD

A METHOD OF PREDICTING RELATIVE FED BATCH PRODUCTION TITER OF A PANEL OF CLONALLY-DERIVED PRODUCER CELLS

Application/Publication number: EP 14830805
Date: 2014-12-17
Applicant(s): VALITACELL LTD

A METHOD OF MEASURING ANTIBODY CONCENTRATION IN A SAMPLE

Application/Publication number: EP 15736411
Date: 2015-06-18
Applicant(s): VALITACELL LTD

A METHOD OF MEASURING ANTIBODY CONCENTRATION IN A SAMPLE

Application/Publication number: EP 15736411
Date: 2015-06-18
Applicant(s): VALITACELL LTD

A METHOD OF PREDICTING PHENOTYPIC INSTABILITY IN A CELL

Application/Publication number: EP 15718799
Date: 2015-04-02
Applicant(s): VALITACELL LTD

A METHOD OF PREDICTING RELATIVE FED BATCH PRODUCTION TITER OF A PANEL OF CLONALLY-DERIVED PRODUCER CELLS

Application/Publication number: EP 14830805
Date: 2014-12-17
Applicant(s): VALITACELL LTD

A METHOD OF PREDICTING PHENOTYPIC INSTABILITY IN A CELL

Application/Publication number: EP 15718799
Date: 2015-04-02
Applicant(s): VALITACELL LTD

A METHOD OF PREDICTING RELATIVE FED BATCH PRODUCTION TITER OF A PANEL OF CLONALLY-DERIVED PRODUCER CELLS

Application/Publication number: EP 14830805
Date: 2014-12-17
Applicant(s): VALITACELL LTD

Trademark (3)

chemstress

Application/Publication number: TM 017262511
Date: 2018-02-12
Applicant(s): VALITACELL LTD

chemstress

Application/Publication number: TM 017262511
Date: 2018-02-12
Applicant(s): VALITACELL LTD

chemstress

Application/Publication number: TM 017262511
Date: 2018-02-12
Applicant(s): VALITACELL LTD